Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mg
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn
Trial Timeline
Jan 1, 2012 → May 1, 2012
NCT ID
NCT01587885About Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mg
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mg is a approved stage product being developed by Bayer for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT01587885. Target conditions include Heartburn.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01587885 | Approved | Completed |
Competing Products
20 competing products in Heartburn